TAICHUNG, TAIWAN (May 15, 2014) -- Bio-medical Carbon Technology Co., Ltd. (BCT), a leading global wound dressing developer and manufacturer, announced the Shanghai Municipal Price Bureau, on May 13, 2014, has issued and published prices for KoCarbonAg Silver Bandage, the flagship product developed and manufactured by BCT, on all models. This indicates BCT’s silver advanced wound dressings can be legally marketed and sold in all cities and provinces of the People’s Republic of China (PRC).
The Chinese advanced wound dressing market had reached RMB 40 billion (US$6.42 billion) in 2012. The China government, in order to promote the use of advanced wound dressings, has raised the product standards and mandated that all Class III advanced wound dressings must be approved by the China Food and Drug Administration (CFDA) and have their prices be reviewed and published by governmental agencies before marketing.
KoCarbonAg Silver Bandage has received many clinical evidences from hospitals in Taiwan and other countries to be proven effective to prevent wound infections, relieve pains and promote wound healing.
About Bio-medical Carbon Technology
Bio-medical Carbon Technology, BCT, develops and manufactures ionic silver coated activated carbon fiber wound care dressings. Its products with proven effectiveness backed by the laboratory tests and clinical trials can treat a broad range of wound types, both acute and chronic wounds. It is proven that its products provide an easy, gentle, faster wound healing. BCT operates worldwide and is supported by its professionals and ongoing development and research. For more information, please visit www.bm-carbon.com